How do we calculate nucleotide diversity when there are pairwise insertions/deletions ?
-
-
I think the most standard approach is to just ignore them (only use biallelic SNPs). This seem good enough for most purposes.Originally posted by ymc View Post
I'm not a all sure how one would properly incorporate them. I suppose it depends on what exactly you are trying to really measure.
One simple approach would be to treat both SNPs and indels as generic markers/alleles. You wouldn't be calculating "nucleotide diversity" as such, more like "allelic diversity". One potential complexity is the different mutation rates, which could mess up estimating stuff like rates of divergence using the metric.
BTW: No one really cares about nucleotide diversity... It is easy to measure and correlated with or a proxy for stuff we do care about though.Comment
-
CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).
Despite this, “CRISPR helped turn genome editing from a specialized technique into...07-31-2026, 11:01 AM -
Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.
The systematic characterization of the human proteome has...07-20-2026, 11:48 AM -
Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
...07-09-2026, 11:10 AM
Comment